Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
An expanded access/compassionate use protocol that allows access to Mylotarg for relapsed/refractory AML CD33 positive patients in the USA.

Contact: B1761026@iconplc.com
CD33 Positive Acute Myelogenous Leukemia
BIOLOGICAL: Antibody Drug Conjugate Chemotherapeutic
Contact:

B1761026@iconplc.com